Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
University of Florida
City of Hope Medical Center
Institut Curie
Brigham and Women's Hospital
Washington University School of Medicine
Sichuan Enray Pharmaceutical Sciences Company
University of Alabama at Birmingham
Instituto do Cancer do Estado de São Paulo
Northwestern University
Centro di Riferimento Oncologico - Aviano
University of Pittsburgh
Institut de Cancérologie de Lorraine
NRG Oncology
University Hospital Southampton NHS Foundation Trust
Abramson Cancer Center at Penn Medicine
Alliance for Clinical Trials in Oncology
Ohio State University Comprehensive Cancer Center
OHSU Knight Cancer Institute
Ohio State University Comprehensive Cancer Center
NYU Langone Health